K
Klaus Seppi
Researcher at Innsbruck Medical University
Publications - 366
Citations - 25650
Klaus Seppi is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Parkinsonism & Medicine. The author has an hindex of 74, co-authored 317 publications receiving 20534 citations. Previous affiliations of Klaus Seppi include University of Innsbruck.
Papers
More filters
Journal ArticleDOI
Imaging markers of disease progression in multiple system atrophy
TL;DR: A review of recent research findings as a tool to assess longitudinal changes of serial neuroimaging-derived parameters in MSA concludes that sample size estimates based on rates of progression of these neuroim imaging markers are reasonable.
Journal ArticleDOI
Axial myopathy in parkinsonism.
Julia Wanschitz,Martin Sawires,Klaus Seppi,Sylvia Boesch,Wolfgang N. Loescher,Michael Schocke,Werner Poewe +6 more
TL;DR: In this article, the authors used EMG, MRI, and biopsy studies of paravertebral muscles provided consistent evidence of extensor myopathy, showing that axial rigidity represents an additional predisposing factor in patients with degenerative parkinsonism.
Journal ArticleDOI
Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study.
Sabine Eschlböck,Gustav Kiss,Florian Krismer,Alessandra Fanciulli,Christine Kaindlstorfer,Cecilia Raccagni,Klaus Seppi,Stefan Kiechl,Jalesh N. Panicker,Gregor K. Wenning +9 more
TL;DR: Urological dysfunction in patients with multiple system atrophy is one of the main manifestations of autonomic failure androdynamic examination is clinically relevant since underlying pathophysiology of lower urinary tract dysfunction can be variable.
Journal ArticleDOI
Undetected ophthalmological disorders in Parkinson’s disease
Carlijn D.J.M. Borm,Mario Werkmann,Debbie de Graaf,F. Visser,Arno Hofer,Marina Peball,Katarzyna Smilowska,Diana Putz,Klaus Seppi,Werner Poewe,Carel B. Hoyng,Bastiaan R. Bloem,Thomas Theelen,Nienke M. de Vries +13 more
TL;DR: In this paper , the authors report on a subgroup of 102 patients with Parkinson's disease who received complete ophthalmological assessment aimed at identifying clinically relevant OMD, which were classified as either vison-threatening or not.
Journal ArticleDOI
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
Marina Peball,Klaus Seppi,Florian Krismer,Hans-Günther Knaus,Sabine Spielberger,Beatrice Heim,Philipp Ellmerer,Mario Werkmann,Werner Poewe,Atbin Djamshidian +9 more
TL;DR: The synthetic tetrahydrocannabinol analogue nabilone improved overall non‐motor symptom (NMS) burden in Parkinson's disease patients in comparison to placebo.